Ocrelizumab extended dosing in Primary Progressive Multiple Sclerosis during the COVID-19 pandemic: a multicenter experienceE. D'Amico, C. Avolio,G. Lus,S. Bonavita,D. Ferraro, G. Callari,S. Barone, F. Patti,F. Granella, A. ZanghiMULTIPLE SCLEROSIS JOURNAL(2022)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要